Topline results were announced from a phase 3 trial evaluating SC pembrolizumab with berahyaluronidase alfa in metastatic NSCLC.
In IPF, antifibrotic therapy discontinuation was linked to patient variables that included depression, lower DLCO, and higher all-cause mortality.
Machine learning analysis of photo and video data demonstrates a promising way to noninvasively detect early hypertension and diabetes.
Casirivimab and imdevimab in combination is safe among pediatric outpatients with at least 1 risk factor for severe COVID-19.
Global coverage with measles vaccination declined during the COVID-19 pandemic, and estimated measles cases increased 20 percent worldwide from 2022 to 2023.
Combat exposure was associated with a 12% increase in insomnia risk and 48% increase in sleep apnea risk among active-duty soldiers.
Influenza-related hospitalization rates in the US varied significantly from 2010/2011 through the 2022/2023, an MMWR report found.
During pregnancy, women should receive recommended COVID-19 vaccines to protect themselves, as well as their young infants.
GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...
In COPD pulmonary rehabilitation, the GOLD COPD criteria may be superior to STAR in anticipating dyspnea perception and exercise capacity.
When evaluating sleep apnea and dementia risk, investigators found that older adults with vs without OSA had a higher incidence of dementia.
Beta-blocker treatment can lead to a modest increase in depressive symptoms among patients who have myocardial infarction with preserved left ventricular ejection fraction (LVEF).